Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. (CDIO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cdio · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cardio Diagnostics Holdings, Inc. (CDIO) measures how much investors pay for each dollar of the company's trailing earnings. CDIO's current PE ratio of N/A is calculated by dividing its stock price of $1.99 by its TTM earnings per share of -$2.34.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cardio Diagnostics Holdings, Inc.You CDIO | $4M | N/A | — | -$2.34 |
 Adial Pharmaceuticals, Inc. ADIL | $2M | N/A | — | -$11.93 |
 Addex Therapeutics Ltd ADXN | $4M | N/A | — | -$7.20 |
 BioCardia, Inc. BCDA | $5M | N/A | — | -$1.23 |
 Brainstorm Cell Therapeutics Inc. BCLI | $9M | N/A | — | -$1.11 |
 Creative Medical Technology Holdings, Inc. CELZ | $6M | N/A | — | -$2.52 |
 Impact BioMedical Inc. IBO | $7M | N/A | — | -$0.38 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-3.71 | — | |
2024-12-31 FY2024 | — | $-0.31 | — | |
2023-12-31 FY2023 | — | $-19.81 | — | |
2022-12-31 FY2022 | — | $-1.51 | — | |
2021-12-31 FY2021 | — | $-1.96 | — | |
2020-12-31 FY2020 | — | $-0.06 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cardio Diagnostics Holdings, Inc. (CDIO) measures how much investors pay for each dollar of the company's trailing earnings. CDIO's current PE ratio of N/A is calculated by dividing its stock price of $1.99 by its TTM earnings per share of -$2.34.
Frequently asked questions
CDIO pe ratio · 6 questionsCDIO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.99 and TTM EPS of -$2.34. Data sourced from Financial Modeling Prep via CDIO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cardio Diagnostics Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09